GENinCode (GENI) Competitors

GENinCode (LON:GENI) and Abingdon Health (LON:ABDX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking and institutional ownership.

Do analysts recommend GENI or ABDX?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GENinCode	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Abingdon Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the MarketBeat Community favor GENI or ABDX?

GENinCode and Abingdon Health both received 0 outperform votes by MarketBeat users.

Company	Underperform	Outperform
GENinCode	N/A	N/A
Abingdon Health	N/A	N/A

Which has more volatility & risk, GENI or ABDX?

GENinCode has a beta of 0.66, meaning that its share price is 34% less volatile than the S&P 500. Comparatively, Abingdon Health has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500.

Does the media refer more to GENI or ABDX?

In the previous week, Abingdon Health had 1 more articles in the media than GENinCode. MarketBeat recorded 1 mentions for Abingdon Health and 0 mentions for GENinCode. GENinCode's average media sentiment score of 0.00 equaled Abingdon Health'saverage media sentiment score.

Company	Overall Sentiment
GENinCode	Neutral
Abingdon Health	Neutral

Is GENI or ABDX more profitable?

GENinCode has a net margin of 0.00% compared to Abingdon Health's net margin of -41.82%. Abingdon Health's return on equity of -76.65% beat GENinCode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GENinCode	N/A	-84.23%	-43.64%
Abingdon Health	-41.82%	-76.65%	-26.52%

Do institutionals and insiders hold more shares of GENI or ABDX?

41.6% of GENinCode shares are held by institutional investors. Comparatively, 10.6% of Abingdon Health shares are held by institutional investors. 29.5% of GENinCode shares are held by company insiders. Comparatively, 56.1% of Abingdon Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Which has higher earnings and valuation, GENI or ABDX?

Abingdon Health has higher revenue and earnings than GENinCode. Abingdon Health is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GENinCode	£1.72M	8.49	-£6.73M	-£0.06	-137.50
Abingdon Health	£5.34M	2.61	-£2.23M	-£0.01	-1,100.00

Summary

Abingdon Health beats GENinCode on 7 of the 12 factors compared between the two stocks.